DAXOR CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Daxor Corporation on January 20, 2022. The report addresses a corporate action regarding the listing status of the Company's common stock, which trades under the symbol DXR.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing transfer and does not contain financial statement data.
Material Changes
On January 20, 2022, the Company announced plans to transfer the listing of its common stock from the NYSE American Exchange to the Nasdaq Stock Market. Until the transfer is complete, shares will continue to trade on the NYSE American Exchange.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, outlook, risks, contingencies, or unusual items. The primary disclosure is the procedural change in the stock exchange listing.
Investor Verification Checklist
- Confirm the effective date of the listing transfer from NYSE American to Nasdaq.
- Verify if the transfer has been completed or if shares are still trading on the NYSE American Exchange.
- Review the attached Press Release (Exhibit 99) for any additional details regarding the transfer rationale.